先正达和诺维信有 宣布 他们正在进入 Taegro 的商业化阶段。两家公司最初于 2012 年联手开发和销售该产品，现已在比利时、保加利亚、捷克共和国、法国、德国、希腊、洪都拉斯、意大利、荷兰、罗马尼亚、斯洛文尼亚、西班牙获得第一批产品批准和英国。预计在未来 12 个月内，欧盟和拉丁美洲还将获得其他几项批准，这将使 2020 年推出多项产品成为可能。
“We’re delighted to see our collaboration with Novozymes entering the commercialization phase and excited about our launch plans. Over the last seven years, our journey together deepened our understanding of biologicals, and we are pleased to place a new tool in the hands of farmers,” comments Jean-Philippe Albert, Global Head of Disease Control at Syngenta.
“This collaboration matches Syngenta’s global market strength in biocontrol and dedication to bring novel technologies to market with Novozymes’ deep knowledge of sustainable, biological solutions,” says Thomas Batchelor, Novozymes’ Vice President of BioAg Commercial. “As the developer and producer of Taegro, we are really excited to see another microbial technology become available to farmers to help them sustainably combat crop diseases and avoid significant yield losses.”